Rome, Italy

Pietro Laneve


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Pietro Laneve - Innovator in Biochemical Research**

Introduction

Pietro Laneve is a distinguished inventor based in Rome, Italy, noted for his contributions to biochemical research. With a single patent to his name, Laneve has made significant strides in understanding endoribonuclease activity, particularly in relation to small nuclear RNA.

Latest Patents

Pietro Laneve's patent, titled "Purification, cloning and biochemical characterization of XendoU, endoribonucleasic activity involved in small nuclear RNA splicing-independent biosynthesis in Xenopus laevis," revolves around the cloning and characterization of the gene for M-dependent RNA sc endoribonuclease activity. This innovation is crucial as it generates 2'-3′ cyclic phosphate and 5′OH ends, playing a vital role in RNA processing and biological research.

Career Highlights

Laneve's career has been marked by his association with prestigious institutions such as the University of Rome "La Sapienza" and the National Research Council (Consiglio Nazionale delle Ricerche). His work has not only enriched academic research but has also contributed to practical applications in biochemistry and molecular biology.

Collaborations

Throughout his career, Pietro Laneve has collaborated with notable researchers, including Irene Bozzoni and Elisa Caffarelli. These partnerships have fostered innovative research and development in the fields of molecular biology and genetics, further underscoring Laneve's impact on the scientific community.

Conclusion

Pietro Laneve stands out as a prominent figure in biochemical innovation. His work exemplifies the vital intersection of academic research and practical application, contributing significantly to the understanding of RNA processes. With his patent and collaborative efforts, Laneve continues to influence the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…